C
Chipman Rg Stroud
Researcher at East Carolina University
Publications - 1
Citations - 220
Chipman Rg Stroud is an academic researcher from East Carolina University. The author has contributed to research in topics: Tocilizumab & Nivolumab. The author has an hindex of 1, co-authored 1 publications receiving 133 citations.
Papers
More filters
Journal ArticleDOI
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
Chipman Rg Stroud,Aparna Madhukeshwar Hegde,Cynthia R. Cherry,Abdul Rafeh Naqash,Nitika Sharma,Srikala Addepalli,Sulochana Devi Cherukuri,Teresa Parent,Jessica Hardin,Paul R. Walker +9 more
TL;DR: Tocilizumab may be a therapeutic option for the management of steroid refractory irAEs secondary to immune checkpoint blockade, however, randomized trials are needed to better elucidate the relative efficacy and safety of these agents.